Loading
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (1 ops.)
Latest filing published 02 Sept 2025 for Assura plc.
Filing timeline
BuySaleJonathan Murphy
Insider track record
Disclosed buys
11
Disclosed sells
1
Signal history
Closed purchases
Market purchases
11
Positive at T+90
40%
Median T+90
+0.0%
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +34.9%Entry CHF 467.00 · Close at T+365 CHF 630.15
- +38.2%Entry CHF 438.00 · Close at T+365 CHF 605.50
- +7.1%Entry CHF 436.00 · Close at T+365 CHF 467.05
- +3.9%Entry CHF 436.00 · Close at T+365 CHF 453.00
- -0.5%Entry CHF 435.00 · Close at T+365 CHF 433.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jonathan Murphy: trading record in brief
Jonathan Murphy is CEO of Assura plc, a British company, and the record, 82 filings published from August 9, 2016 to September 2, 2025, is dominated by 70 grants. The market side holds 8 purchases worth EUR 244,606, median EUR 16,597, and one sale of EUR 15,775 on June 12, 2020. Purchases make up 89% of market trades.
The largest purchases are EUR 100,185 on May 21, 2024, EUR 65,301 on June 2, 2023 and EUR 45,336 on December 6, 2017. The record also holds 3 filings of another kind.
The calendar tightens around 2021 (18 filings), 2022 (17) and 2024 (15), while 2016 and 2017 hold just one each. No filing falls in the last twelve months. Filings appear a median of 2 days after the trade. Murphy has 7, 5 and 3 own market trades within 30 days of colleagues at Assura plc, in that order. Same side: 6, 5 and 3. In the same order, the colleagues are Jayne Cottam, Ed Smith and Louise Fowler.
Companies and markets linked to Jonathan Murphy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations82 total
3,518,426 sharesXLONISIN GB00BVGBWW93RNS:5803935-3
663 shares@ £0.49390.1% of flowXLONISIN GB00BVGBWW93RNS:5769867-0
1,251 shares@ £0.49980.1% of flowXLONISIN GB00BVGBWW93RNS:5735398-0
676 shares@ £0.4810.1% of flowXLONISIN GB00BVGBWW93RNS:5690036-0
663 shares@ £0.49010.1% of flowXLONISIN GB00BVGBWW93RNS:5644801-0
607 shares@ £0.47690.1% of flowXLONISIN GB00BVGBWW93RNS:5618763-0
754 shares@ £0.43270.1% of flowXLONISIN GB00BVGBWW93RNS:5609274-0
918 shares@ £0.3630.1% of flowXLONISIN GB00BVGBWW93RNS:5582107-0
786 shares@ £0.41320.1% of flowXLONISIN GB00BVGBWW93RNS:5564471-0
878 shares@ £0.36920.1% of flowXLONISIN GB00BVGBWW93RNS:5531346-0
851 shares@ £0.38280.1% of flowXLONISIN GB00BVGBWW93RNS:5491445-0
800 shares@ £0.40560.1% of flowXLONISIN GB00BVGBWW93RNS:5460646-0
819 shares@ £0.39770.1% of flowXLONISIN GB00BVGBWW93RNS:5422683-0
584 shares@ £0.410.1% of flowXLONISIN GB00BVGBWW93RNS:5386636-1
Canonical exit: 7 Jan 2025 (T+90)
773 shares@ £0.41830.1% of flowXLONISIN GB00BVGBWW93RNS:5381603-0
800 shares@ £0.40870.1% of flowXLONISIN GB00BVGBWW93RNS:5340989-0
5,632 shares@ £0.41270.5% of flowXLONISIN GB00BVGBWW93RNS:5303540-0
459 shares@ £0.42560.0% of flowXLONISIN GB00BVGBWW93RNS:5264783-1
Canonical exit: 8 Oct 2024 (T+90)
1,905,505 sharesXLONISIN GB00BVGBWW93RNS:5264301-0
774 shares@ £0.41960.1% of flowXLONISIN GB00BVGBWW93RNS:5258468-0
773 shares@ £0.41990.1% of flowXLONISIN GB00BVGBWW93RNS:5218311-0
198,975 shares@ £0.4320.1% of flowXLONISIN GB00BVGBWW93RNS:5192178-0
Canonical exit: 19 Aug 2024 (T+90)
774 shares@ £0.42210.1% of flowXLONISIN GB00BVGBWW93RNS:5174711-0
406 shares@ £0.420.0% of flowXLONISIN GB00BVGBWW93RNS:5144946-1
Canonical exit: 9 Jul 2024 (T+90)
786 shares@ £0.41310.1% of flowXLONISIN GB00BVGBWW93RNS:5134250-0
25 of 82 declarations
